pharmaceuticals
Pandemic keeps Rite Aid (RAD) busy after mixed Q4; underlying weakness to persist
Rite Aid Corporation (NYSE: RAD) recently witnessed a spurt in store traffic as people rushed to stock up on medicines…
Johnson & Johnson retaining Dividend King status lifts the overall mood of the economy
Until a couple of days back, we could only speculate on the impact of COVID-19 on the economy. Of course,…
Stock Analysis: COVID-19 testing kit gives Abbott (ABT) an edge over Boston Scientific (BSX)
When Wall Street suffered huge losses after business activity was disrupted across the country due to the COVID-19 outbreak, one…
What’s in store for Rite Aid (RAD) Q4 earnings?
Drugstore chain Rite Aid (NYSE: RAD) is slated to report its fourth-quarter and full-year 2020 results on Thursday, April 16…
Rite Aid (RAD) stock retreats on recession, growth concerns
The concerns have been mounting for Rite Aid Corporation (NYSE: RAD) as the fight against the raging COVID-19 pandemic has…